Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
838
-
Total 13F shares, excl. options
-
235M
-
Shares change
-
-3.87M
-
Total reported value, excl. options
-
$44.2B
-
Value change
-
-$695M
-
Put/Call ratio
-
1.23
-
Number of buys
-
371
-
Number of sells
-
-364
-
Price
-
$188.13
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2017
917 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2017.
Elevance Health, Inc. - Common Stock (ELV) has 838 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 235M shares
.
Largest 10 shareholders include BlackRock Inc. (22.7M shares), VANGUARD GROUP INC (17.8M shares), PRICE T ROWE ASSOCIATES INC /MD/ (13.5M shares), STATE STREET CORP (11.3M shares), FMR LLC (10.1M shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (6.65M shares), BAILLIE GIFFORD & CO (4.96M shares), WELLINGTON MANAGEMENT GROUP LLP (4.32M shares), Orbis Allan Gray Ltd (4.25M shares), and Invesco Ltd. (4.25M shares).
This table shows the top 838 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.